Swatting away a takeover attempt, Zymeworks keeps retooling staff; After Cygnal-ing her exit from Flagship, Pearl Huang starts afresh

Paul Moore ? Zymeworks used a poison pill maneuver a couple weeks ago as the counterpunch to a $773 million takeover bid by All Blue Falcons, and new CEO Kenneth Galbraith isn’t done piecing the […]

No Picture

STAT+: After abortion ruling, biotechs developing contraceptives say their work is more important — and fraught — than ever

SAN DIEGO — From San Diego to New Jersey, biotechs developing new forms of birth control say they’re doubling down on those efforts after Roe v. Wade was overturned — even as the Supreme Court’s […]